NHS 'not ready' to dish out breakthrough Alzheimer's drug
Top doctors today warned that the NHS is not ready to dish out the medication, made by US-based pharmaceutical giant Eli Lilly, and needs to 'gear up' now in preparation to do so.
Stay updated with breaking news from Discovery Brain Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top doctors today warned that the NHS is not ready to dish out the medication, made by US-based pharmaceutical giant Eli Lilly, and needs to 'gear up' now in preparation to do so.
The genetic study showed promising results in "silencing" the genes that translate into tau protein, the primary component behind dementia.
Researchers say the findings are a ‘significant’ step forward in demonstrating that it may be possible to target the protein to slow the disease.
Researchers say the findings are a ‘significant’ step forward in demonstrating that it may be possible to target the protein to slow the disease.
Genetic therapy was able to halve the amount of harmful protein in the brain